Login / Signup

Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P-TIMI 50 trial.

Benjamin L FreedmanDavid D BergBenjamin M SciricaErin A BohulaErica L GoodrichMarc S SabatineDavid A MorrowMarc P Bonaca
Published in: Clinical cardiology (2023)
Keyphrases
  • heart failure
  • phase iii
  • study protocol
  • risk factors
  • phase ii
  • cardiovascular disease
  • clinical trial
  • left ventricular
  • randomized controlled trial
  • atrial fibrillation
  • open label
  • type diabetes